News About: Pharm. Industry
KPMA discusses damages of drug price cutback
The Korea Pharmaceutical Manufacturers Association plans to assess the damage that the government's unilateral measures to reduce drug prices would cause in domestic pharmaceutical industry in the future and map out p...
Drug wholesalers alert over Dong-A's margin cut
Domestic wholesalers, which have had difficulty coping with various negative factors, have again showed concerns over Dong-A Pharm's imminent margin slash over ethical products.
According to pharmaceutical business...
Choong-wae Medical operates Chungju plantChoong-wae Medical, an affiliate of Choong-wae Holdings, is beginning production of medical devices, such as digital X-ray system and electrically powered operation tables, in a...
|
Prescription sales of leading anti-obesity drugs stuck in doldrums
Makers of leading anti-obesity medicines were hardest hit by the season influence in the period ranging from October 2007 to January this year.
Analysts say, however, that the anti-obesity market will pick up...
KFDA opens drug related web site
The Korea Food and Drug Administration opened an internet website to provide users with administrativeaffairs on drug related licenses, re-evaluation, re-examination and safety information.
The measure aims to enco...
Hyundai's split shares are on stock market
Hyundai Pharm says its stocks revalued at 500 won per share have been again traded on the main bourse from March 28.
Hyundai shares will gain on share split, analysts say.
The company closed at 45,300 won on Mar...
Three associate wholesalers selected as Novartis's Dynacirc distributors
Novartis Korea says it has selected three associate wholesalers to exclusively distribute its antihypertensive agent Dynacirc (isradipine) throughout the country.
The three wholesalers include Sejong Medical, Sins...
Government mulls introduction of reference price system
The government is considering implementing a reference price system (RPS) by stages in a bid to complement the current new pricing policy, an official of the Ministry of Health, Welfare and Family Affairs said in a lo...
KRPIA to support scientific events by third party
The controversial third-party support for scientific events may subdue as member companies of the KRPIA seem to be positive.
Changing their negative response over the issues, the KRPIA expressed an intension to col...
Seo named Novartis Asia-Pacific managerSeo Sang-ok, chief director of Novartis Korea, has been appointed as manager of Novartis's Asia and Pacific unit in Singapore for one year ranging from March this year to Februa...
|
